search

Active clinical trials for "Lymphoma, T-Cell"

Results 621-630 of 706

A Study of Liposome-entrapped Mitoxantrone Hydrochloride Injection in Relapsed/Refractory Peripheral...

Relapsed or Refractory Peripheral T-cell and NK/T-cell Lymphoma

This is a single-arm, open, multi-center, phase II study to evaluate the efficacy and safety of Mitoxantrone Hydrochloride Liposome Injection in Relapsed or refractory peripheral t-cell and NK/T-cell lymphoma.

Unknown status56 enrollment criteria

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide...

Peripheral T Cell Lymphoma

The PIGLETS regimen was devised to replace the conventional SMILE regimen in management of extranodal NK/T cell lymphoma in our institution. It had been three years since the introduction of PIGLETS regimen in treatment of NK malignancies. The response rate is encouraging, with an overall response rate (ORR) of 90% in NK malignancies. Side effects are generally tolerable. The investigator therefore propose the use of PIGLETS on newly diagnosed or relapsed/refractory PTCLs.

Unknown status7 enrollment criteria

GLIDE Regimen Followed by ASCT for Aggressive NK/T Cell Lymphoma

LymphomaExtranodal NK-T-Cell

This study is to explore the efficacy and safety of GLIDE regiment in patients with aggressive NK/T cell lymphoma.

Unknown status8 enrollment criteria

Efficacy and Safety of Decitabine Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell...

Peripheral T-cell Lymphoma

Primary objective of the study is to compare the efficacy and safety of decitabine plus CHOP (D-CHOP) versus CHOP alone in patients with previously untreated peripheral T-cell lymphoma (PTCL).

Unknown status27 enrollment criteria

Tofacitinib Combined With Chidamide in R/R ENKTCL

Extranodal NK/T-cell Lymphoma

This study is to explore the efficacy and safety of tofacitinib combined with chidamide in patients with relapsed and refractory extranodal NK/T cell lymphoma.

Unknown status7 enrollment criteria

Chidamide With ICE Regimen for Relapsed/Refractory Peripheral T Cell Lymphoma

Peripheral T Cell Lymphoma

The purpose of this study is to evaluate the efficacy and safety of Chidamide with ICE regimen in patients with relapsed/refractory Peripheral T Cell lymphoma.

Unknown status21 enrollment criteria

Study of Apatinib and MASCT in Patients With Advanced Solid Tumors

Advanced Solid TumorsExcluding T Cell Lymphoma

The study is aimed to evaluate the efficacy and safety of Apatinib and MASCT in patients with advanced solid tumors.

Unknown status31 enrollment criteria

CAR-pNK Cell Immunotherapy in CD7 Positive Leukemia and Lymphoma

Acute Myeloid LeukemiaPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma9 more

The purpose of this study is to evaluate the safety and effectiveness of CAR-pNK cell immunotherapy in patients with CD7 positive relapsed or refractory Leukemia and Lymphoma.

Unknown status19 enrollment criteria

A Study of SHC014748M in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma

Peripheral T Cell Lymphoma

The purpose of this study is to evaluate the efficacy and safety of SHC014748M in patients with relapsed or refractory relapsed or refractory Peripheral T Cell Lymphoma.

Unknown status27 enrollment criteria

Lenalidomide and Sintilimab for Relapsed/Refractory NK/T-cell Lymphoma

NK/T Cell Lymphoma Nos

The purpose of this study is to evaluate the efficacy and safety of Sintilimab in combination with lenalidomide in the treatment of Relapsed/Refractory NK/T-cell lymphoma patients who failed pegaspargase-based regimens.

Unknown status18 enrollment criteria
1...626364...71

Need Help? Contact our team!


We'll reach out to this number within 24 hrs